Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IxCell hUC-MSC-O in Knee Osteoarthritis Dose-Finding Phase II Trial
CTR20210039Phase 2Completed
- Sponsor
- Shanghai Aisair Biotechnology
- Start
- Jan 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of IxCell hUC-MSC-O in knee osteoarthritis (OA), sponsored by Shanghai Aisair Biotechnology. Started Jan 2021; status: completed.
02
Drugs
IxCell hUC-MSC-O
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20210039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210039.